StoneX Group Inc.

Position in RNXT — RenovoRx, Inc.

CIK 913760 New York, NY

Position in RNXT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$12,855

New position

Shares Held

12,728

first reported quarter

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 31 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

StoneX Group Inc. holds $1,825,991 across 16 Biotechnology names. RNXT ranks #6 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,482	$661,772
2	PRAX	Praxis Precision Medicines, Inc.	1,469	$473,297
3	HRMY	Harmony Biosciences Holdings, Inc.	12,631	$353,794
4	HALO	Halozyme Therapeutics, Inc.	3,650	$235,899
5	CDXS	Codexis, Inc.	14,096	$22,976
6	RNXT	RenovoRx, Inc. This page	12,728	$12,855
7	MREO	Mereo BioPharma Group plc	36,873	$12,168
8	HUMA	Humacyte, Inc.	16,205	$9,836

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,855	12,728	—	Shares	Defined	2026-05-14
No filing history on record for this holder in this stock.